Skip to main content

Table 1 Baseline characteristics of the study population

From: Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

Demographics

 

 Mean age (years)

50 ± 12 (20–77)

 Male sex

74 % (88)

HCV genotype

 

 1a

20 % (23)

 1b

44 % (53)

 2

12 % (14)

 3

20 % (24)

 4

4 % (5)

Mean HCV-RNA (10E6 IU ml-1)

3.23 ± 6.61 (0.02–34.50)

Cirrhosis

46 % (55)

Treatment history

 

 Treatment naive

50 % (59)

 Treatment experienced

50 % (60)

 Protease inhibitor experienced

23 % (27)

Clinical chemistry

 

 Platelets (10E3 μl-1)

155 ± 74 (13–396)

 Total bilirubin (mg dl-1)

1.0 ± 0.8 (0.2–4.7)

 INR

1.09 ± 0.25 (0.84–2.65)

 Creatinine (mg dl-1)

0.78 ± 0.21 (0.43–1.85)

  1. Data are expressed as percent (number) or means ± SD (range)